IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.522
NA - Nord America 10.471
EU - Europa 4.072
SA - Sud America 1.913
AF - Africa 225
Continente sconosciuto - Info sul continente non disponibili 166
OC - Oceania 55
AN - Antartide 1
Totale 32.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.020
SG - Singapore 8.506
CN - Cina 2.720
HK - Hong Kong 2.225
IT - Italia 1.904
BR - Brasile 1.390
VN - Vietnam 776
GB - Regno Unito 670
FR - Francia 544
BD - Bangladesh 415
DE - Germania 262
CA - Canada 240
IN - India 226
AR - Argentina 186
ID - Indonesia 133
NL - Olanda 120
MX - Messico 103
EC - Ecuador 101
CO - Colombia 95
TR - Turchia 80
ZA - Sudafrica 80
UA - Ucraina 75
JP - Giappone 73
ES - Italia 62
IQ - Iraq 58
RU - Federazione Russa 53
AU - Australia 50
PL - Polonia 45
CL - Cile 40
FI - Finlandia 38
PY - Paraguay 36
SA - Arabia Saudita 36
CZ - Repubblica Ceca 33
MA - Marocco 32
AT - Austria 31
SE - Svezia 30
JM - Giamaica 29
PK - Pakistan 28
PE - Perù 26
VE - Venezuela 26
EG - Egitto 23
MD - Moldavia 23
PH - Filippine 23
PT - Portogallo 22
RO - Romania 22
TN - Tunisia 22
UZ - Uzbekistan 20
CR - Costa Rica 19
MY - Malesia 16
KZ - Kazakistan 15
NP - Nepal 15
IL - Israele 14
JO - Giordania 14
KE - Kenya 13
LT - Lituania 13
TH - Thailandia 13
HN - Honduras 12
IE - Irlanda 12
IR - Iran 12
OM - Oman 12
DK - Danimarca 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
BG - Bulgaria 10
EE - Estonia 10
GT - Guatemala 10
LB - Libano 10
DZ - Algeria 9
AZ - Azerbaigian 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
KR - Corea 8
SV - El Salvador 8
BE - Belgio 7
GR - Grecia 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
KW - Kuwait 6
NI - Nicaragua 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BO - Bolivia 5
CG - Congo 5
GH - Ghana 5
HU - Ungheria 5
LU - Lussemburgo 5
LV - Lettonia 5
SN - Senegal 5
PA - Panama 4
PS - Palestinian Territory 4
QA - Qatar 4
SI - Slovenia 4
TW - Taiwan 4
AF - Afghanistan, Repubblica islamica di 3
BY - Bielorussia 3
CY - Cipro 3
IS - Islanda 3
KG - Kirghizistan 3
Totale 32.186
Salva come PNG Salva come JPEG
Città #
San Jose 2.944
Hong Kong 2.200
Ashburn 2.116
Singapore 1.720
Rome 1.291
Hefei 1.104
Council Bluffs 789
Boardman 618
Columbus 576
London 527
Beijing 491
Lauterbourg 473
Shanghai 359
Dallas 350
Ho Chi Minh City 298
New York 166
Santa Clara 165
Hanoi 152
Los Angeles 146
São Paulo 114
Phoenix 105
Pune 97
San Francisco 95
Amsterdam 78
Toronto 77
Munich 61
Washington 58
Seattle 52
Tokyo 52
Naples 48
Mexico City 47
Milan 44
Brasília 40
Brooklyn 40
Montreal 38
Chicago 37
Haiphong 37
Warsaw 37
Frankfurt am Main 36
Rio de Janeiro 35
Da Nang 34
Las Vegas 34
Guayaquil 33
Atlanta 32
Buffalo 32
Baghdad 31
Ankara 29
Johannesburg 28
Quito 28
Bari 26
Stockholm 24
Turku 23
Biên Hòa 22
Guangzhou 22
Porto Alegre 22
Bogotá 21
Curitiba 21
Nuremberg 21
Buenos Aires 20
Medellín 20
Thái Bình 20
West Jordan 20
Boston 19
Brno 19
Chennai 19
Cape Town 18
Hải Dương 18
Jinan 18
Manchester 18
Belo Horizonte 17
Campinas 17
Florence 17
Kingston 17
Philadelphia 17
Sydney 17
Vienna 17
Guarulhos 16
Hangzhou 16
Lima 16
San José 16
Tashkent 16
The Dalles 16
Turin 16
Charlotte 15
Jakarta 15
Riyadh 15
Changsha 14
Manaus 14
Bologna 13
Can Tho 13
Dhaka 13
Helsinki 13
Madrid 13
Melbourne 13
San Antonio 13
Amman 12
Hortolândia 12
Lấp Vò 12
Ottawa 12
Paris 12
Totale 18.860
Salva come PNG Salva come JPEG
Nome #
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 275
------- 246
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 240
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 237
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 226
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 224
A comprehensive review on adult onset Still's disease 219
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 214
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 211
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 210
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 204
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 204
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 198
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 197
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 195
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 195
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 189
Adult-onset Still's disease with elderly onset: results from a multicentre study 182
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 181
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 177
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 177
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 173
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 172
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 171
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 159
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 146
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 131
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 128
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 126
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 123
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 123
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 122
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 121
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 121
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 119
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 119
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 117
Recent advances and evolving concepts in Still's disease 116
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease 114
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 114
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 113
Cytokine storm syndrome in severe COVID-19 111
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 110
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 109
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 109
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 108
Development and implementation of the AIDA International Registry for patients with Behçet's disease 107
How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model 107
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 107
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 106
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 101
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 101
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 100
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 100
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 100
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 98
Polyclonal B lymphocyte activation in progressive systemic sclerosis. 97
The economic burden of fibromyalgia: A systematic literature review 95
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 95
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 95
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 95
Cardiovascular disease in primary sjögren’s syndrome 93
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 93
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 92
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 91
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 89
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 86
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 85
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 84
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 84
Vascular complications of scleroderma 81
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 81
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis 79
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 78
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 77
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 77
The Vessels Contribute to Fibrosis in Systemic Sclerosis 77
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 76
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 76
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 76
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 76
SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-beta/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-beta RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA 76
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 75
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 74
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 74
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 74
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 73
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 73
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 73
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 72
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications 72
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 72
Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology, and Clinical Implications 72
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 71
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 71
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 71
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 70
Systemic Sjogren presenting without sicca syndrome: characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria 70
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome 70
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 69
Totale 12.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 255.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 255.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022643 0 0 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/202616.151 1.556 496 1.216 2.243 456 944 4.069 1.311 1.231 1.258 801 570
2026/20272.655 183 1.433 1.039 0 0 0 0 0 0 0 0 0
Totale 32.425